Current strategies incorporating immune checkpoint inhibitors for the treatment of advanced or metastatic non-small-cell lung cancers

Future Oncol. 2019 Sep;15(27):3097-3101. doi: 10.2217/fon-2018-0119.
No abstract available

Keywords: NSCLC; PD-1; PDL-1; TKIs; immunotherapy; oncogene addiction.

Publication types

  • Editorial
  • Letter

MeSH terms

  • Antineoplastic Agents, Immunological / administration & dosage
  • Antineoplastic Agents, Immunological / adverse effects
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / etiology
  • Carcinoma, Non-Small-Cell Lung / pathology*
  • Humans
  • Immunomodulation / drug effects*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / etiology
  • Lung Neoplasms / pathology*
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Immunological